International Clinical Trials Day (ICTD) 2026

Stronger Together: Advanced Therapy Clinical Trials Without Borders

We are delighted to announce our International Clinical Trials Day (ICTD) 2026 conference, 'Stronger Together: Advanced Therapy Clinical Trials Without Borders', co-hosted by ECRIN and CZECRIN in Prague. It will take place on Wednesday, May 20, 2026.

Launched in 2005 by ECRIN, in line with its mission to support multinational clinical research in Europe, ICTD brings together patients, health policy actors, health authorities, clinical researchers, health professionals and citizens from Europe, and beyond to discuss issues related to multinational clinical studies. ICTD commemorates the start of the landmark clinical trial, led by James Lind on sailors with scurvy, 20 May 1747. Having laid the foundation for modern clinical research, ECRIN salutes this initiative by addressing a new topic in clinical research every year on or around this date.

Stronger Together
Advanced Therapy Medicinal Products (ATMPs) represent a rapidly evolving area of clinical research, encompassing gene therapies, cell therapies, and tissue-engineered products designed to address diseases with high unmet medical need. Clinical research on ATMPs is characterised by complex trial designs, and unlike conventional drugs, it requires close integration of clinical protocols with GMP-compliant manufacturing, and long-term follow-up to monitor durability of effect and potential delayed risks. As a result, regulatory, ethical, and logistical considerations play a central role in ATMP clinical research and are increasingly complex when we want to work across borders.

Agenda (draft below)
The day is broken down into 3 parts, the first of which is setting the scene where the keynote speaker will discuss cross cutting challenges in ATMP clinical trials and a study will present the difficulties encountered when trying to bring their study across borders. The majority of the day is then spent on the different stakeholder perspectives including patients, regulators, health technology assessment, sponsors, funders and investigators. To close the day, we move from challenges to solutions. How do we improve? A high-level reflection on the European efforts is shared and then discussed in a panel session.

Register below to join us. Please note places for onsite are limited and offered on a first come, first served basis.